Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cash-Strong Vical Narrows Focus To Two Lead Programs

Dec 05 2008

Related Content

Vical Picks Up $6.3M More For Phase III

Jun 12 2008

Vical To Retain Marketing Rights To Allovection-7 In Deal With AnGes

May 30 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window